Doxorubicin
TEVA Doxorubicin Hydrochloride Injection is a sterile, red‑orange solution formulated for intravenous use. Each mL provides 2 mg doxorubicin hydrochloride in an isotonic, preservative‑free base containing 0.9% sodium chloride, water for injection, and hydrochloric acid to adjust pH to a target of 3.0. Classified as an antineoplastic agent, this product carries DIN 02409275 and is available by prescription in Canada. Supplied in professional-use vials for administration in controlled clinical settings. Available in 5 mL (10 mg) and 25 mL (50 mg) presentations to support prescribed protocols.
Original: $53.72
-65%$53.72
$18.80
Description
TEVA Doxorubicin Hydrochloride Injection is a sterile, red‑orange solution formulated for intravenous use. Each mL provides 2 mg doxorubicin hydrochloride in an isotonic, preservative‑free base containing 0.9% sodium chloride, water for injection, and hydrochloric acid to adjust pH to a target of 3.0. Classified as an antineoplastic agent, this product carries DIN 02409275 and is available by prescription in Canada. Supplied in professional-use vials for administration in controlled clinical settings. Available in 5 mL (10 mg) and 25 mL (50 mg) presentations to support prescribed protocols.
